The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
December 4th 2024
CDC, NIH, and AMA recommend PEMs to be at a 6th-to-8th-grade reading level, while assessed materials were readable at high school or higher levels.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
CASPAR Criteria for Psoriatic Arthritis Adapt Well for Retrospective Use
March 3rd 2012The sensitivity, specificity, and feasibility of the ClASsification criteria for Psoriatic ARthritis (CASPAR) are maintained when they are adapted for retrospective use to classify an established research cohort from medical records.
Widespread Practice of Defensive Medicine Reported at Orthopedic Meeting
February 10th 2012Defensive medicine-ordering tests, making referrals to specialists, and approving hospital admissions primarily to avoid liability and without providing significant benefit to patients-has been practiced by virtually all orthopedic surgeons, according to a study presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in San Francisco.
Judging Osteoporosis Screening Intervals From the Latest T Score
February 1st 2012(AUDIO) Data from a long-term prospective study reveal that, for many older women, the pace of bone mass deterioration takes place on the scale of decades, not single years. Here, the lead author of the study describes how to interpret the results to choose the date for your own patient's next bone-density test.
Osteoporosis Study Suggests Bone Density Testing Intervals for Older Women
February 1st 2012Osteoporosis would develop in fewer than 10% of older, postmenopausal women during rescreening intervals of about 15 years for those with normal bone density or mild osteopenia, 5 years for those with moderate osteopenia, and 1 year for those with advanced osteopenia, according to a study reported in The New England Journal of Medicine.
Maintenance Therapy for Lupus Nephritis Study Results Favor Mycophenolate Mofetil
February 1st 2012In patients with lupus nephritis who have a response to induction therapy, mycophenolate mofetil is superior to azathioprine in maintaining a renal response to treatment and in preventing relapse, according to the results of a study reported in The New England Journal of Medicine.
Nearly Half of RA Patients Are Sedentary. Here's Why.
January 27th 2012Lack of conviction and motivation, not pain or depression, appear to be the major factors that deter nearly half of RA patients from moving about enough to ease their symptoms. Chicago researchers suggest what should be done about this.
Many Rheumatoid Arthritis Patients are Physically Inactive
January 26th 2012More than two in five adults with rheumatoid arthritis are physically inactive, to the detriment of their health, researchers at the Northwestern University Feinberg School of Medicine report in a study published online today in Arthritis Care & Research.
Physicians Stop RA Medications Too Soon Before Surgery
January 20th 2012Doctors may be halting use of anti-tumor necrosis factor (anti-TNF) medications too early in rheumatoid arthritis (RA) patients who are set to undergo surgery, researchers at the Hospital for Special Surgery (HSS) in New York City have found.
Potential New Target for RA Treatment
January 14th 2012A potential way to halt the cartilage destruction that occurs with rheumatoid arthritis (RA) without suppressing the immune system has been identified by a new study supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Top 10 Lupus Achievements in 2011
January 14th 2012A year of historic lupus firsts generated during 2011 contributed to advances in the science and medicine of lupus, improved lupus awareness, and heightened understanding of the disease and its impact, according to the Lupus Foundation of America (LFA).